CoChat

SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020

Velumani, Arokiaswamy, Nikam, Chaitali, Suraweera, Wilson, Fu, Sze Hang, Gelband, Hellen, Brown, Patrick, Bogoch, Isaac, Nagelkerke, Nico, Jha, Prabhat · 2021
PreprintCited by 15

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

SUMMARY: Objectives: We sought to understand the spread of SARS-CoV-2 infection in urban India, which has surprisingly low COVID-19 deaths. Design: Cross-sectional and trend analyses of seroprevalence in self-referred test populations, and of reported cases and COVID mortality data. Participants: 448,518 self-referred individuals using a nationwide chain of private laboratories with central testing of SARS-CoV-2 antibodies and publicly available case and mortality data. Setting: 12 populous cities with nearly 92 million total population. Main outcome measures: Seropositivity trends and predictors (using a Bayesian geospatial model) and prevalence derived from mortality data and infection fatality rates (IFR). Results: For the whole of India, 31% of the self-referred individuals undergoing antibody testing were seropositive for SARS-CoV-2 antibodies. Seropositivity was higher in females (35%) than in males (30%) overall and in nearly every age group. In these 12 cities, seroprevalence rose from about 18% in July to 41% by December, with steeper increases at ages <20 and 20-44 years than at older ages. The “M-shaped” age pattern is consistent with intergenerational transmission. Areas of higher childhood measles vaccination in earlier years had lower seropositivity. The patterns of increase in seropositivity and in peak cases and deaths varied substantially across cities. In Delhi, death rates and cases first peaked in June and again in November; Chennai had a single peak in July. Based local IFRs and COVID deaths (adjusted for undercounts), we estimate that 43%-65% of adults above age 20 had been infected (range of mid-estimates of 12%-77%) corresponding 26 to 36 million infected adults in these cities, or an average of 9-12 infected adults per confirmed case. Conclusion: Even with relatively low death rates, the large cities of India had remarkably high levels of SARS-CoV-2 infection. Vaccination strategies need to consider widespread intergenerational transmission.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.03.19.21253429

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 23

  1. Brown P , Rai K , La Vecchia C , et al. Mortality from COVID-19 in 12 countries and 6 states of the United States. medRxiv 2020. doi: https://doi.org/10.1101/2020.04.17.20069161. Available from https://covid.cghr.dev/. · doi:10.1101/2020.04.17.20069161
  2. 10.1016/S2214-109X(19)30451-6 · DOI · Paper page
  3. 2021, High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?, Epidemiology and Infection, 149, e39., 10.1017/S0950268821000273 · DOI
  4. 10.1016/S2214-109X(20)30467-8 · DOI · Paper page
  5. Ghose A , Bhattacharya S , Karthikeyan AS , et al. Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in five localities in an Indian metropolitan city. medRxiv 2020 Dec. doi: https://doi.org/10.1101/2020.11.17.20228155 · DOI
  6. 10.1001/jama.2021.0332 · DOI
  7. 10.1007/s10668-020-00878-9 · DOI · Paper page
  8. 2020, COVID-19 seroprevalence study of an Indian Diagnostic Laboratory-Report on gender and age analysis, Asian Journal of Health Sciences, 6, 16
  9. 2020, Income distribution and inequality in India: 2014-19. arXiv preprint
  10. Hammer MS , van Donkelaar A , Li C , et al. Global Estimates and Long-Term Trends of Fine Particulate Matter Concentrations (1998-2018). Environmental Science & Technology. 2020 Jun 3. doi: https://pubs.acs.org/doi/10.1021/acs.est.0c01764 · DOI · Paper page
  11. WorldPop and Center for International Earth Science Information Network (CIESIN), Columbia University (2018). Global High Resolution Population Denominators Project. doi: https://dx.doi.org/10.5258/SOTON/WP00649 · doi:10.5258/soton/wp00649
  12. 2015, Model-based geostatistics the easy way. Journal of Statistical Software, 63, 1
  13. 2020, SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys, The Lancet Global Health, 8, e1390, 10.1016/S2214-109X(20)30387-9 · DOI · Paper page
  14. 10.1016/S1473-3099(20)30858-6 · DOI · Paper page
  15. 2015, One-person households in India, Demographic Research, 32, 1239, 10.4054/DemRes.2015.32.45 · DOI
  16. 2021, SARS-CoV-2 antibody seroprevalence in India, August– September, 2020: findings from the second nationwide household serosurvey, The Lancet Global Health, 9, e257, 10.1016/S2214-109X(20)30544-1 · DOI · Paper page
  17. 2020, Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis, PLoS Med, 17, 21003346
  18. Byambasuren O , Cardona M , Bell K , Clark J , McLaws ML , Glasziou P. Estimating the extent of asymptomatic covid-19 and its potential for community transmission: Systematic review and meta-analysis, Off. J. Assoc. Med. Microbiol. Infect. Dis. Canada COVID-19, e20200030 (2020) · DOI
  19. 2021, Infectivity of asymptomatic versus symptomatic COVID-19, The Lancet, 397, 93, 10.1016/S0140-6736(20)32651-9 · DOI · Paper page
  20. 10.1126/science.abc4262 · DOI
  21. 10.1136/bmj.m3018 · DOI
  22. 10.1016/S2214-109X(19)30451-6 · DOI · Paper page
  23. 2020, Defining the Epidemiology of Covid-19 – Studies Needed, New England Journal of Medicine, 382, 1194, 10.1056/NEJMp2002125 · DOI · Paper page

Cited by

See all 15

Metadata

Authors
Velumani, A., Nikam, C., Suraweera, W., Fu, S. H., Gelband, H., Brown, P., Bogoch, I., Nagelkerke, N., & Jha, P.
Publisher
openRxiv
Published
2021-03-24
Cited by
15
References
5
Type
Preprint

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. https://app.cochat.ai/papers/10.1101/2021.03.19.21253429
The paper
Velumani, A., Nikam, C., Suraweera, W., Fu, S. H., Gelband, H., Brown, P., Bogoch, I., Nagelkerke, N., & Jha, P. (2021). SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. https://doi.org/10.1101/2021.03.19.21253429

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.